Drug and Alcohol Treatment Program — Brighton Center for Recovery
Drug and Alcohol Treatment Program — Brighton Center for Recovery – A Brighton Center for Recovery patient describes her former addiction problem and her path to recovery with the help of program counselors, doctors, and staf…
Lilly's Investigational GLP-1 Receptor Agonist, Dulaglutide, Showed Superior …
Filed under: drug treatment programs maryland
"These results are a promising step forward in our effort to provide a new, once-weekly GLP-1 treatment option, giving patients another choice to help manage their diabetes," said Sherry Martin, M.D., senior medical director, Lilly Diabetes. … Today …
Read more on MarketWatch
Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational …
Filed under: drug treatment programs maryland
[2] Results from this additional analysis showed that among those who completed the Phase II study, which included eight weeks of treatment with LY2605541 and eight weeks of insulin glargine, LY2605541 led to significantly lower average blood glucose …
Read more on MarketWatch
Long-Term Study Reports Deep Brain Stimulation Effective for Most Common …
Filed under: drug treatment programs maryland
Michele Tagliati, MD, neurologist, director of the Movement Disorders Program at Cedars-Sinai Medical Center's Department of Neurology, and Ron L. Alterman, MD, chief of the Division of Neurosurgery at Beth Israel Deaconess Medical Center in Boston …
Read more on Science Daily (press release)
ELI LILLY & CO. : Phase III data show investigational compound empagliflozin …
Filed under: drug treatment programs maryland
"This study is part of the Boehringer Ingelheim and Lilly Diabetes alliance's clinical program designed to examine empagliflozin as an add-on therapy to a broad range of existing treatments for people with type 2 diabetes," said Christophe Arbet-Engels …
Read more on 4-traders (press release)